A recent study on patients with Graves’ orbitopathy unfolded that MMP-2, MMP-9, TIMP-1 and TIMP-2 serum concentrations were all significantly higher than healthy controls (Kapelko-Słowik et al., 2018). This evidence concerns the gene MMP2 and Graves ophthalmopathy.